SCHEMBL6175347

SCHEMBL6175347

CCCCCCNC(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 9/20 0.50
TSHR P16473 2/20 0.48
ALDH1A1 P00352 2/20 0.48
THRB P10828 1/20 0.44
ADH1B P00325 1/20 0.44
ADH1C P00326 1/20 0.44
ADH1A P07327 1/20 0.44
ADH4 P08319 1/20 0.44
ADH7 P40394 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
FAAH O00519 1/20 0.41
MAPK1 P28482 1/20 0.41
HRH4 Q9H3N8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
PPARA Q07869 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
XBP1 P17861 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3365367 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL183108 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL8417287 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL6899503 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL23945383 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL6899576 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL23696489 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL19038581 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL7770496 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B
SCHEMBL1026323 1.00 EPHX1 (0.50) EPHX1TSHRALDH1A1THRBADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640669-B2 Carbon black composition for manufacturing particulate magnetic recording medium and method of manufacturing particulate magnetic recording medium FUJIFILM CORPORATION (JP) 2020-05-05 US claimed
US-20170088741-A1 CARBON BLACK COMPOSITION FOR MANUFACTURING PARTICULATE MAGNETIC RECORDING MEDIUM AND METHOD OF MANUFACTURING PARTICULATE MAGNETIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2017-03-30 US claimed
CN-101588880-B Use of amine blends for foundry cores and foundry metals ARKEMA FRANCE 2012-03-07 CN claimed
CN-101588880-A Use of amine blends for foundry cores and foundry metals ARKEMA FRANCE (FR) 2009-11-25 CN claimed
EP-0672739-B1 THERMOREVERSIBLE THICKENER SANYO CHEMICAL IND LTD (JP) 2001-01-03 EP claimed
US-5840977-A CYCLOHEXANOL UREA DERIVATIVE AS INTERMEDIATE FUJIREBIO INC. (JP) 1998-11-24 US claimed
EP-0612740-A1 Methods of producing pantothenic acid derivative and its starting materials for producing the same FUJIREBIO Inc. (JP) 1994-08-31 EP claimed
US-4224208-A Tire protection composition NEW WORLD PRODUCTS, INC. (US) 1980-09-23 US claimed
US-4137206-A Tire protection composition NEW WORLD PRODUCTS, INC. (US) 1979-01-30 US claimed
EP-4644399-A1 METHOD FOR PRODUCING NITROGEN-CONTAINING POLYFUNCTIONAL ORGANOXYSILANE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-11-05 EP disclosed
US-20250333426-A1 METHOD FOR PRODUCING NITROGEN-CONTAINING POLYFUNCTIONAL ORGANOXYSILANE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-10-30 US disclosed
US-20230398223-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-12-14 US disclosed
US-20230322715-A1 BROAD SPECTRUM ANTI-CANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-10-12 US disclosed
US-20230303526-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-09-28 US disclosed
US-4417052-A ANTIINFLAMMATORY AGENTS; ANALGESICS; VIRICIDES STERLING DRUG INC. (US) 1983-11-22 US disclosed
EP-0052204-A1 Prostacyclin analogs of the 1 series and related analogs AMERICAN CYANAMID COMPANY (US) 1982-05-26 EP disclosed
US-4308382-A ANTIINFLAMMATORY AGENTS STERLING DRUG INC. (US) 1981-12-29 US disclosed
US-4301078-A SMOOTH MUSCLE STIMULATORS THE UPJOHN COMPANY (US) 1981-11-17 US disclosed
US-4216326-A Intermediates for preparing anti-inflammatory phenyl-lower-alkylamines STERLING DRUG INC. (US) 1980-08-05 US disclosed
US-4069256-A Anti-inflammatory phenyl-lower-alkylamines STERLING DRUG INC. (US) 1978-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333426-A1 METHOD FOR PRODUCING NITROGEN-CONTAINING POLYFUNCTIONAL ORGANOXYSILANE COMPOUND H1-10, H1-0, ARG1 EPHX1 1203/4885TSHR 1096/4885ALDH1A1 3088/4885
US-20230398223-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 EPHX1 1684/4885TSHR 3319/4885ALDH1A1 2776/4885
US-20230322715-A1 BROAD SPECTRUM ANTI-CANCER COMPOUNDS YTHDF1, YTHDF3, YTHDF2 EPHX1 4134/4885TSHR 2302/4885ALDH1A1 4553/4885
US-20230303526-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 EPHX1 1684/4885TSHR 3319/4885ALDH1A1 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.